Detalles de la búsqueda
1.
Participant Fraud in Virtual Qualitative Substance Use Research: Recommendations and Considerations for Detection and Prevention Based on a Case Study.
Subst Use Misuse
; 59(8): 1261-1270, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503716
2.
Identifying appropriate outcomes to help evaluate the impact of the Canadian Guideline for Safe and Effective Use of Opioids for Non-Cancer Pain.
BMC Anesthesiol
; 20(1): 6, 2020 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31910806
3.
Cardiovascular and Neuropsychiatric Events after Varenicline Use for Smoking Cessation.
Am J Respir Crit Care Med
; 197(7): 913-922, 2018 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29260881
4.
Impact of large-scale distribution and subsequent use of free nicotine patches on primary care physician interaction.
BMC Public Health
; 18(1): 4, 2017 07 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28693456
5.
Incorporating sex, gender and vulnerable populations in a large multisite health research programme: The Ontario Pharmacy Evidence Network as a case study.
Health Res Policy Syst
; 15(1): 20, 2017 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28320403
6.
The Ontario Pharmacy Evidence Network Atlas of Smoking Cessation Services.
Can Pharm J (Ott)
; 155(4): 194-199, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813528
7.
Impact of self-reported lifetime depression or anxiety on effectiveness of mass distribution of nicotine patches.
Tob Control
; 26(5): 526-533, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27543563
8.
Reply to Goulden et al.: Risk of Bias in Study of Varenicline and Cardiovascular Outcomes.
Am J Respir Crit Care Med
; 198(5): 691-692, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29708391
9.
A pharmacist framework for implementation of the Canadian Guideline for Opioids for Chronic Non-Cancer Pain.
Can Pharm J (Ott)
; 152(1): 35-44, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30719196
10.
Pharmacy in the 21st century: Enhancing the impact of the profession of pharmacy on people's lives in the context of health care trends, evidence and policies.
Can Pharm J (Ott)
; 152(1): 45-53, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30719197
11.
Characteristics, treatment patterns and retention with extended-release subcutaneous buprenorphine for opioid use disorder: A population-based cohort study in Ontario, Canada.
Drug Alcohol Depend
; 254: 111032, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38043224
12.
Guidance on opioid tapering in the context of chronic pain: Evidence, practical advice and frequently asked questions.
Can Pharm J (Ott)
; 151(2): 114-120, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29531629
13.
Protocol for a qualitative study exploring the pharmacist's role in supporting postsecondary students with psychotropic medication management.
BMJ Open
; 13(9): e072976, 2023 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37696640
14.
Physician and nurse practitioner perspectives of a modified Routine Opioid Outcome Monitoring (ROOM) Tool.
J Prim Health Care
; 15(3): 246-252, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37756229
15.
Assessing the impact of the slow-release oral morphine drug shortages in Ontario, Canada: A population-based time series analysis.
Int J Drug Policy
; 118: 104119, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429161
16.
Psychosocial and pharmacologic interventions for problematic methamphetamine use: Findings from a scoping review of the literature.
PLoS One
; 18(10): e0292745, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37819931
17.
Predictors of and reasons for early discharge from inpatient withdrawal management settings: A scoping review.
Drug Alcohol Rev
; 41(1): 62-77, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34041795
18.
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.
Addiction
; 117(7): 1972-1981, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35257434
19.
Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada.
Pain
; 163(1): e129-e136, 2022 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326293
20.
The role of pharmacists in opioid stewardship: A scoping review.
Res Social Adm Pharm
; 18(5): 2714-2747, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34261590